Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | LPO | P22079 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2333736 | 0.77 | L3MBTL1 (0.57) | KDM4EALDH1A1ACHEL3MBTL1LMNA | |
| Hydrochloric Acid SCHEMBL6095500 | 0.76 | L3MBTL1 (0.56) | KDM4EALDH1A1ACHEL3MBTL1LMNA | |
| SCHEMBL4928504 | 0.75 | KDM4E (0.47) | KDM4EALDH1A1LMNACA1HPGD | |
| SCHEMBL6024645 | 0.74 | KDM4E (0.43) | KDM4EALDH1A1L3MBTL1LMNASHMT2 | |
| Hydrochloric Acid SCHEMBL4304760 | 0.74 | L3MBTL1 (0.54) | KDM4EALDH1A1ACHEL3MBTL1LMNA | |
| SCHEMBL6024686 | 0.74 | ERN1 (0.51) | KDM4EALDH1A1L3MBTL1LMNACA1 | |
| SCHEMBL16965192 | 0.73 | UPP1 (0.58) | KDM4EALDH1A1L3MBTL1LMNAHPGD | |
| SCHEMBL18081923 | 0.71 | ALDH1A1 (0.41) | KDM4EALDH1A1LMNACA1GAA | |
| SCHEMBL590303 | 0.71 | ALDH1A1 (0.41) | KDM4EALDH1A1LMNACA1HPGD | |
| SCHEMBL1326868 | 0.68 | KDM4E (0.62) | KDM4EALDH1A1L3MBTL1LMNACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820211-A | Synthesis method of 4-hydroxy-5, 6-dimethylpyridine-2 (1H) -one | 上海毕得医药科技股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-20260125389-A1 | MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF | HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN) | 2026-05-07 | — | — | US | disclosed |
| CN-119894902-A | Membrane associated tyrosine and threonine kinase inhibitors and uses thereof | 海南先声再明医药股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-117820211-A | Synthesis method of 4-hydroxy-5, 6-dimethylpyridine-2 (1H) -one | 上海毕得医药科技股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117820211-A | Synthesis method of 4-hydroxy-5, 6-dimethylpyridine-2 (1H) -one | 上海毕得医药科技股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117820211-A | Synthesis method of 4-hydroxy-5, 6-dimethylpyridine-2 (1H) -one | 上海毕得医药科技股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-1511746-A2 | PROCESS FOR IMIDAZO[4,5-C]PYRIDIN-4-AMINES | 3M Innovative Properties Company (US) | 2005-03-09 | — | — | EP | disclosed |
| US-6743920-B2 | CHORINATION REPLACING HYDROXYL GROUPS OF 2,4-DIHYROXY-3-NITROPYRIDINE DERIVATIVE; AMINATION, HYDROXYARYLATION, REDUCTION AND CYCLIZATION; AMINE REPLACEMENT OF PHENOXY FUNCTIONALITY | 3M INNOVATIVE PROPERTIES COMPANY | 2004-06-01 | — | — | US | disclosed |
| US-20030232852-A1 | Process for imidazo[4,5-c]pyridin-4-amines | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-18 | — | — | US | disclosed |
| WO-2003101949-A2 | PROCESS FOR IMIDAZO[4,5-C]PYRIDIN-4-AMINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232852-A1 | Process for imidazo[4,5-c]pyridin-4-amines | CPNE4, HTR4, IL4 | KDM4E 136/4885ALDH1A1 2377/4885ACHE 1268/4885 |
| US-20260125389-A1 | MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF | PKMYT1, PKN1, ROS1 | KDM4E 1448/4885ALDH1A1 4554/4885ACHE 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.